Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Working Capital/Sales

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 4.325.238.608.177.07

What is the latest Working Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Working Capital/Sales ratio of PIRAMAL PHARMA is 4.32 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20264.32
Mar20255.23
Mar20248.60
Mar20238.17
Mar20227.07

How is Working Capital/Sales of PIRAMAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2026 4.32
-17.40
Mar2025 5.23
-39.19
Mar2024 8.6
5.26
Mar2023 8.17
15.56
Mar2022 7.07 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Working Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹31,132.5 Cr 0.5% 18.3% 18.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,150.0 Cr 0.8% -2.1% 4.8% Stock Analytics
DIVIS LABORATORIES ₹266,265.0 Cr 4.9% 7.9% 54.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr 1.6% -2.7% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹114,351.0 Cr 2.6% 14.2% 3.9% Stock Analytics
CIPLA ₹112,474.0 Cr 2.4% 3.4% -12% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.5%

18.3%

18.6%

SENSEX

4.5%

6.1%

-9.3%


You may also like the below Video Courses